Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RETHINK REFLUX Registry

NCT: NCT04253392 · ACTIVE_NOT_RECRUITING

NCT IDNCT04253392
StatusACTIVE_NOT_RECRUITING
Start Date2020-07-08
Completion2032-07-31

Brief Summary

The RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. The primary objective of the study is to confirm the long-term safety profile of the LINX device and procedure (implant/explant) up to 10 years post-implant.

Frequently Asked Questions

What is RETHINK REFLUX Registry?

RETHINK REFLUX Registry is a clinical trial registered under NCT04253392. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04253392?

The current status of NCT04253392 (RETHINK REFLUX Registry) is: ACTIVE_NOT_RECRUITING.

When did RETHINK REFLUX Registry start?

RETHINK REFLUX Registry started on 2020-07-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.